Treating aggression in the psychiatric emergency service
- PMID: 12672260
Treating aggression in the psychiatric emergency service
Abstract
Reports indicate that the severely mentally ill, those patients with schizophrenia or bipolar disorder, are at increased risk of being violent to others. They are also at increased risk of being victims of violence or homicide. This article discusses the state of knowledge concerning the 3 most common classes of drugs used to decrease agitation in the psychiatric emergency service setting: benzodiazepines, conventional antipsychotics, and atypical antipsychotics. The decision whether to use benzodiazepines alone versus benzodiazepines combined with an antipsychotic, and whether that antipsychotic should be a conventional or atypical antipsychotic, hinges on considerations of mental health history, need for synergistic sedating effects, and the side effect profiles of the various medications.
Similar articles
-
A review of agitation in mental illness: treatment guidelines and current therapies.J Clin Psychiatry. 2006;67 Suppl 10:13-21. J Clin Psychiatry. 2006. PMID: 16965191 Review.
-
Atypical antipsychotic medications in the psychiatric emergency service.J Clin Psychiatry. 2000;61 Suppl 14:21-6. J Clin Psychiatry. 2000. PMID: 11154013 Review.
-
Agitation in the inpatient psychiatric setting: a review of clinical presentation, burden, and treatment.J Psychiatr Pract. 2011 May;17(3):170-85. doi: 10.1097/01.pra.0000398410.21374.7d. J Psychiatr Pract. 2011. PMID: 21586995 Review.
-
Managing the aggressive and violent patient in the psychiatric emergency.Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jun;30(4):586-98. doi: 10.1016/j.pnpbp.2006.01.015. Epub 2006 Mar 6. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16571365 Review.
-
Pharmacological management of aggression and violence.Hum Psychopharmacol. 2003 Aug;18(6):423-36. doi: 10.1002/hup.504. Hum Psychopharmacol. 2003. PMID: 12923820 Review.
Cited by
-
Critical Issues in the Management of Agitation, Aggression, and End-of-Life in Delusional Disorder: A Mini-Review.Healthcare (Basel). 2023 Feb 5;11(4):458. doi: 10.3390/healthcare11040458. Healthcare (Basel). 2023. PMID: 36832992 Free PMC article. Review.
-
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.Psychopharmacology (Berl). 2006 Oct;188(3):281-92. doi: 10.1007/s00213-006-0541-x. Epub 2006 Sep 5. Psychopharmacology (Berl). 2006. PMID: 16953381 Clinical Trial.
-
Psychiatric emergency services: a review of the literature and a proposed research agenda.Psychiatr Q. 2005 Summer;76(2):139-65. doi: 10.1007/s11089-005-2336-0. Psychiatr Q. 2005. PMID: 15884742 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical